The Highly Productive
Thermothelomyces heterothallica C1
filamentous fungi
influenza vaccine
recombinant protein expression
targeted influenza hemagglutinin
trimeric influenza hemagglutinin
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
20 Jan 2022
20 Jan 2022
Historique:
received:
29
10
2021
revised:
11
01
2022
accepted:
12
01
2022
entrez:
26
2
2022
pubmed:
27
2
2022
medline:
27
2
2022
Statut:
epublish
Résumé
(1) Influenza viruses constantly change and evade prior immune responses, forcing seasonal re-vaccinations with updated vaccines. Current FDA-approved vaccine manufacturing technologies are too slow and/or expensive to quickly adapt to mid-season changes in the virus or to the emergence of pandemic strains. Therefore, cost-effective vaccine technologies that can quickly adapt to newly emerged strains are desirable. (2) The filamentous fungal host
Identifiants
pubmed: 35214607
pii: vaccines10020148
doi: 10.3390/vaccines10020148
pmc: PMC8877961
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Nature. 1987 May 7-13;327(6117):59-61
pubmed: 3472080
Vaccine. 2005 Dec 30;23(50):5708-24
pubmed: 16154667
Int J Parasitol. 2017 Jun;47(7):435-446
pubmed: 28153778
Mycologia. 2015 May-Jun;107(3):619-32
pubmed: 25661719
Hum Vaccin Immunother. 2018;14(8):1874-1882
pubmed: 29672213
Trends Ecol Evol. 2017 Jan;32(1):55-67
pubmed: 28029378
PLoS Pathog. 2010 Jan 29;6(1):e1000745
pubmed: 20126449
Science. 2004 Mar 19;303(5665):1838-42
pubmed: 14764886
Mol Cell Proteomics. 2019 Dec;18(12):2348-2358
pubmed: 31604803
Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10224-8
pubmed: 9707628
Rev Sci Tech. 2000 Apr;19(1):310-7
pubmed: 11189723
J Immunol. 1986 Jan;136(1):58-65
pubmed: 3079611
Euro Surveill. 2019 Feb;24(9):
pubmed: 30862331
Rev Sci Tech. 2014 Aug;33(2):569-81
pubmed: 25707184
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Front Public Health. 2020 Jul 29;8:383
pubmed: 32850602
Ther Adv Vaccines. 2015 Jul;3(4):97-108
pubmed: 26478817
Appl Environ Microbiol. 2013 Feb;79(4):1316-24
pubmed: 23241981
Arch Med Res. 2017 Nov;48(8):701-716
pubmed: 29398104
Pathogens. 2016 Dec 06;5(4):
pubmed: 27929449
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
EBioMedicine. 2021 Dec;74:103699
pubmed: 34801965
Hum Vaccin Immunother. 2018;14(8):1840-1847
pubmed: 29641358
Vaccines (Basel). 2021 Jun 15;9(6):
pubmed: 34203630
Vaccine. 2008 Sep 12;26 Suppl 4:D49-53
pubmed: 19230160
Blood. 2002 Aug 15;100(4):1153-9
pubmed: 12149191
J Immunol. 2016 Nov 1;197(9):3575-3585
pubmed: 27671110
Nat Biotechnol. 2011 Oct 02;29(10):922-7
pubmed: 21964414
J Virol. 1986 Dec;60(3):833-9
pubmed: 3783818
N S W Public Health Bull. 2011 Jul;22(5-6):113-7
pubmed: 21781618
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Virology. 1990 Mar;175(1):59-68
pubmed: 2309452
Vaccines (Basel). 2021 Sep 29;9(10):
pubmed: 34696209
J Virol. 2014 Mar;88(5):2844-57
pubmed: 24371052
Vaccines (Basel). 2021 Mar 13;9(3):
pubmed: 33805749
Biotechnol Bioeng. 2007 Aug 1;97(5):1028-38
pubmed: 17221887
Anal Bioanal Chem. 2021 Dec;413(30):7559-7585
pubmed: 34739558
Microbiol Rev. 1992 Mar;56(1):152-79
pubmed: 1579108
Hum Vaccin Immunother. 2017 Jul 3;13(7):1640-1652
pubmed: 28532276
Mol Ther. 2006 Apr;13(4):776-85
pubmed: 16414309
Annu Rev Biochem. 2000;69:531-69
pubmed: 10966468
Bull World Health Organ. 1974;51(1):1-11
pubmed: 4218138
Nat Rev Immunol. 2019 Jun;19(6):383-397
pubmed: 30837674
Front Immunol. 2019 Mar 27;10:594
pubmed: 30972078
Front Immunol. 2015 Jul 20;6:367
pubmed: 26257735
Front Immunol. 2021 Aug 31;12:710647
pubmed: 34531860
Crit Rev Biotechnol. 2016;36(1):59-69
pubmed: 25025273
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Metab Eng. 2020 Sep;61:416-426
pubmed: 31078793